Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

NIH Awards $15 Million Grant to UCSF-CFAR

Published: Thursday, October 18, 2012
Last Updated: Thursday, October 18, 2012
Bookmark and Share
UCSF-CFAR awarded more than $15 million over the next five years to continue UCSF-Gladstone AIDS research.

The National Institutes of Health (NIH) has awarded more than $15 million over the next five years to the UCSF-Gladstone Center for AIDS Research (CFAR) to continue its pioneering translational AIDS research. It’s the sixth renewal of the center’s grant.

The UCSF-Gladstone CFAR, one of 21 federally funded such centers nationwide, provides strategic, educational and scientific services to HIV/AIDS researchers through pilot grants totaling approximately $750,000 per year.

The center conducts a nationally recognized mentoring program between well established UCSF faculty investigators and early career researchers pursuing HIV research at UCSF or affiliated institutes, and provides essential infrastructure through its clinical and population sciences, immunology, virology, specimen bank and pharmacology cores. It also provides support to more than $80 million of funded HIV/AIDS research at UCSF and affiliated institutions.

The UCSF-Gladstone CFAR has played a crucial role in maintaining and extending the leadership role of San Francisco in responding to the HIV epidemic since its inception as one of the first CFARs funded almost 25 years ago, said co-director Warner Greene, MD, PhD, director of the Gladstone Institute of Virology and Immunology and UCSF professor of medicine.

“We are a CFAR that seeks to be nimble and responsive, constantly asking where the field is moving and how we can help position our community to respond to new and emerging topics in HIV research,” Greene said.

Greene continued, “As an example of how our CFAR operates and its impact, one of the hottest topics in HIV right now is research towards a cure. HIV latency is one of the fundamental obstacles to achieving a cure.”

HIV latency is the processes through which HIV manages to hide and persist in various cells and tissues in HIV-infected persons even after many years of successful suppression of the virus using antiretroviral medication.

The UCSF-Gladstone CFAR provided initial pilot funding for HIV latency research in 2003, and the findings generated by that research led to the NIH awarding the first major HIV latency program project grant, Greene said.

The research conducted with that grant then helped lead to the NIH’s Delaney Collaborative initiative last year, providing $80 million to three collaboratories - two of which involved UCSF and Gladstone investigators - seeking to develop a cure for HIV, he added.

The center has succeeded in stimulating several advances in HIV/AIDS research, including:

• Delineating the biology of the APOBEC3G protein in anti-viral immunity;
• Boosting thymic function;
• Understanding changes in viral “fitness” as a result of antiretroviral drug resistance;
• Better diagnosis and understanding of atherosclerosis in HIV;
• Pioneering the use of anti-retroviral medications by HIV-negative individuals to prevent acquisition of HIV (pre-exposure prophylaxis); and
• Studying the interactions between HIV and malaria.

Furthering NIH’s Mission for AIDS Research
The mission of the NIH CFAR program, first funded in 1988, is “to support a multi-disciplinary environment that promotes basic, clinical, epidemiologic, behavioral and translational research in the prevention, detection and treatment of HIV infection and AIDS.”

Looking ahead, the center has identified three key areas of investigation:

• Implementation of combination prevention - the bundling of proven behavioral interventions with biomedical interventions such as pre-exposure prophylaxis, male circumcision and treatment to dramatically reduce the rates of new infections;
• Understanding how HIV infection affects and accelerates the aging process; and
• Finding a cure for those already infected.

CFAR co-director Paul Volberding, MD, director of the UCSF AIDS Research Institute and professor of medicine at UCSF, said the center has been focusing on work in Africa, where it held the first Sub-Saharan Africa CFAR Conference last year in Kampala, Uganda, bringing together 240 researchers from 19 domestic CFARs and collaborators from 13 African countries.

“One of the most rewarding directions our CFAR has taken in recent years has been in building international collaborations, chiefly in East Africa,” Volberding said. “While we are conducting research in many countries, we have built a strong focus in Uganda, Kenya and Tanzania."

On November 8, the center also will host the National Centers for AIDS Research Scientific Symposium, titled “CFAR and HIV Therapy at 25: Seeking an End to AIDS,” at the UCSF Mission Bay Conference Center.

Anthony S. Fauci, MD, director of National Institute of Allergy and Infectious Disease, will be giving the keynote address, and this event will include the recognition of two important silver anniversaries - the establishment of the CFAR network and the introduction of AZT, the first therapeutic for HIV.

Other emerging initiatives for the center include targeting health disparities domestically through partnering with the UCSF Center for AIDS Prevention and the San Francisco Department of Public Health and expanding community engagement by partnering with Project Inform and the Forum for Collaborative Research.

“Even though it is 25 years since our first CFAR grant and in many ways the epidemic has changed dramatically, we continue to work with the same urgency to overcome the challenges that HIV/AIDS poses in the Bay Area, nationally and around the world,” concluded Volberding.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Immune System Implicated in Gastroschisis
UCSF researchers show that the immune system is implicated in gastroschisis. The findings could lead to improved treatments for the belly birth defect.
Tuesday, May 17, 2016
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Tuesday, April 26, 2016
UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation.
Thursday, April 14, 2016
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Wednesday, February 03, 2016
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Thursday, August 20, 2015
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
Thursday, May 21, 2015
Human Cancer Prognosis Is Related to Newly Identified Immune Cell
A rare population of tumor-associated “good” cells slows cancer.
Monday, October 20, 2014
Type 1 Diabetes Drug Proves Effective in Clinical Trial
Drug developed by UCSF researcher shows promise for blocking advance of disease in earliest stages.
Thursday, August 08, 2013
HIV Testing Increased and Infection Reduced in Africa with Community Intervention
Free mobile HIV testing and counseling, same-day results and post-test support reduces HIV infections by 14 percent.
Thursday, March 07, 2013
Stem Cell Survival Strategy Is Key to Blood and Immune System Health
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages.
Monday, February 18, 2013
Multiple Sclerosis ‘Immune Exchange’ Between Brain and Blood is Uncovered
UCSF finding of movement by disease-causing B cells gives hope for new treatments and diagnostics.
Thursday, November 22, 2012
Research Offers New Hope for HIV/AIDS Patients with Cancer
Proposed treatment for herpes virus that causes Kaposi's sarcoma receives translational research funding.
Thursday, August 23, 2012
New Standards to Improve Diagnosis of Sjögren’s Syndrome
UCSF-led team of international researchers develop criteria to identify autoimmune disease.
Tuesday, August 14, 2012
Researchers Identify a Potential New HIV Vaccine/Therapy Target
Investigators first determine levels of Th17 cells in the gut of sixteen rhesus macaques and then infected them with SIV.
Monday, June 04, 2012
Scientific News
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos